The prevalence of coronary artery disease (CAD) in patients with peripheral arterial disease
(PAD) has been well defined. However, the prevalence of PAD in hospitalized patients with …

Background Screening of high-risk groups for peripheral arterial disease has been
advocated because the condition underdiagnosed and secondary prevention can reduce …

AIM: Recent data on the management of cardiovascular risk factors in high risk patients
showed that dyslipidemia is still treated in an inadequate way, especially in diabetic …

The peripheral arterial system includes all noncardiac arteries: the thoracic and abdominal
aortas and their branches extending to visceral organs and both upper and lower extremities …

BACKGROUND Peripheral arterial disease (PAD) is undertreated by general practitioners
(GPs). However, the impact of the suboptimal clinical management is unknown. OBJECTIVE …

Objective The prognosis of patients with peripheral arterial disease (PAD) is characterized
by an exceptionally high risk for myocardial infarction, ischemic stroke, and death; however …

Background Lower extremity peripheral arterial disease (PAD) is a marker of widespread
atherosclerosis. Individuals with PAD, most of whom do not show typical PAD symptoms …

Apolipoprotein B is a stronger predictor of myocardial infarction than LDL cholesterol, and it
is inversely related to physical activity and modifiable with exercise training. As such …

Best medical therapy for peripheral artery disease (PAD) includes statin and anti-platelet
agents, a combination shown to decrease rates of major cardiovascular events. Despite …

The term peripheral arterial disease (PAD) is often used to describe atherosclerosis
involving the arteries supplying the lower extremities. Potentially modifiable factors that …